Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 8/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.48 |
| ▸ | LMNA | P02545 | 4/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.48 |
| ▸ | MEN1 | O00255 | 4/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.48 |
| ▸ | NPC1 | O15118 | 3/20 | 0.48 |
| ▸ | RAB9A | P51151 | 3/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.48 |
| ▸ | MAOA | P21397 | 3/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | HTT | P42858 | 2/20 | 0.48 |
| ▸ | CES2 | O00748 | 1/20 | 0.48 |
| ▸ | APAF1 | O14727 | 1/20 | 0.48 |
| ▸ | TERT | O14746 | 1/20 | 0.48 |
| ▸ | PLIN1 | O60240 | 1/20 | 0.48 |
| ▸ | TDP2 | O95551 | 1/20 | 0.48 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.48 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.48 |
| ▸ | BCHE | P06276 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL83136 | 0.92 | ADORA2A (0.53) | MAPTALDH1A1LMNAMAPK1MEN1 | |
| SCHEMBL1480067 | 0.90 | MAPT (0.47) | MAPTALDH1A1LMNAMAPK1MEN1 | |
| SCHEMBL10883505 | 0.89 | MAOA (0.48) | MAPTALDH1A1LMNAMAPK1NPC1 | |
| SCHEMBL10886395 | 0.86 | ELANE (0.45) | MAPTALDH1A1LMNAMAPK1MEN1 | |
| Boric Acid SCHEMBL29849803 | 0.85 | MAPT (0.47) | MAPTALDH1A1LMNAMAPK1MEN1 | |
| SCHEMBL11550615 | 0.85 | PDK2 (0.47) | MAPTALDH1A1LMNAMAPK1NPC1 | |
| SCHEMBL10063730 | 0.85 | MAPT (0.50) | MAPTALDH1A1LMNAMAPK1MEN1 | |
| SCHEMBL10783896 | 0.85 | PDK2 (0.47) | MAPTALDH1A1LMNAMAPK1NPC1 | |
| SCHEMBL7006710 | 0.85 | PDK2 (0.47) | MAPTALDH1A1LMNAMAPK1NPC1 | |
| SCHEMBL8671230 | 0.83 | ELANE (0.48) | MAPTALDH1A1LMNAMAPK1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115528215-A | Secondary battery positive electrode material pre-ionization reagent and preparation method and application thereof | 深圳珈钠能源科技有限公司 | 2022-12-27 | — | — | CN | claimed |
| CN-113248441-A | Dual-functional ionic liquid, preparation method thereof and application thereof in catalytic synthesis of bisphenol compound | 大连理工大学 | 2021-08-13 | — | — | CN | claimed |
| US-20230373941-A1 | COMPOUNDS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2023-11-23 | — | — | US | disclosed |
| EP-4255151-A2 | SPIRO[FLUORENE-9,9'-(THIO)XANTHENE] COMPOUNDS | Merck Patent GmbH (DE) | 2023-10-04 | — | — | EP | disclosed |
| EP-4113643-B1 | SPIRO[FLUORENE-9,9'-(THIO)XANTHENE] COMPOUNDS | MERCK PATENT GMBH (DE) | 2023-08-09 | — | — | EP | disclosed |
| EP-3523834-B1 | ELECTRONIC DEVICE | MERCK PATENT GMBH (DE) | 2023-01-25 | — | — | EP | disclosed |
| EP-4113643-A1 | ELECTRONIC DEVICE | Merck Patent GmbH (DE) | 2023-01-04 | — | — | EP | disclosed |
| CN-115528215-A | Secondary battery positive electrode material pre-ionization reagent and preparation method and application thereof | 深圳珈钠能源科技有限公司 | 2022-12-27 | — | — | CN | disclosed |
| CN-113248441-A | Dual-functional ionic liquid, preparation method thereof and application thereof in catalytic synthesis of bisphenol compound | 大连理工大学 | 2021-08-13 | — | — | CN | disclosed |
| US-10308607-B2 | Fucosidase inhibitors | HORIZON ORPHAN LLC (US) | 2019-06-04 | — | — | US | disclosed |
| WO-2017019925-A1 | FUCOSIDASE INHIBITORS | RAPTOR PHARMACEUTICALS INC. (US) | 2017-02-02 | — | — | WO | disclosed |
| US-20110166141-A1 | CATHEPSIN S INHIBITORS | DCB-USA, LLC (US) | 2011-07-07 | — | — | US | disclosed |
| EP-0886182-A1 | Positive photoresist composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1998-12-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230373941-A1 | COMPOUNDS FOR ELECTRONIC DEVICES | CYP2E1, GPX1, ERCC1 | MAPT 2951/4885ALDH1A1 115/4885LMNA 2835/4885 |
| US-10308607-B2 | Fucosidase inhibitors | FUCA1, FUCA2, ENGASE | MAPT 3789/4885ALDH1A1 588/4885LMNA 3460/4885 |
| US-20110166141-A1 | CATHEPSIN S INHIBITORS | CTSS, CTSV, CTSB | MAPT 3934/4885ALDH1A1 2734/4885LMNA 4130/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.